Integrated bioinformatics analysis identified leucine rich repeat containing 15 and secreted phosphoprotein 1 as hub genes for calcific aortic valve disease and osteoarthritis

Shuji Gong,Kun Xiang,Le Chen,Huanwei Zhuang,Yaning Song,Jinlan Chen
DOI: https://doi.org/10.1049/syb2.12091
2024-04-04
IET Systems Biology
Abstract:The authors' study identified leucine rich repeat containing 15 (LRRC15) and secreted phosphoprotein 1 (SPP1) as hub genes in calcific aortic valve disease (CAVD) and osteoarthritis (OA) and found that they were related to immune processes. This offers new perspectives on the pathogenesis and treatment of CAVD and OA treatment. Calcific aortic valve disease (CAVD) and osteoarthritis (OA) are common diseases in the ageing population and share similar pathogenesis, especially in inflammation. This study aims to discover potential diagnostic and therapeutic targets in patients with CAVD and OA. Three CAVD datasets and one OA dataset were obtained from the Gene Expression Omnibus database. We used bioinformatics methods to search for key genes and immune infiltration, and established a ceRNA network. Immunohistochemical staining was performed to verify the expression of candidate genes in human and mice aortic valve tissues. Two key genes obtained, leucine rich repeat containing 15 (LRRC15) and secreted phosphoprotein 1 (SPP1), were further screened using machine learning and verified in human and mice aortic valve tissues. Compared to normal tissues, the infiltration of immune cells in CAVD tissues was significantly higher, and the expressions of LRRC15 and SPP1 were positively correlated with immune cells infiltration. Moreover, the ceRNA network showed extensive regulatory interactions based on LRRC15 and SPP1. The authors' findings identified LRRC15 and SPP1 as hub genes in immunological mechanisms during CAVD and OA initiation and progression, as well as potential targets for drug development.
cell biology,mathematical & computational biology
What problem does this paper attempt to address?